NLVP
XLRN

New Leaf Venture Partners’s Acceleron Pharma XLRN Stock Holding History

New Leaf Venture Partners’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-114,621
Closed -$2.85M – 14
2015
Q3 		$2.85M Buy
114,621
+24,883
+28% +$748K 2.48% 8
2015
Q2 		$2.84M Buy
+89,738
New +$2.9M 1.88% 11

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

New Leaf Venture Partners's XLRN Position: Q4 2015 in Review

New Leaf Venture Partners sold out of Acceleron Pharma (XLRN) in Q4 2015, closing a stake of 114,621 shares — an estimated $2.85M sold.

New Leaf Venture Partners first reported a position in XLRN in Q2 2015 and held it in 2 quarters. The position peaked at $2.85M in Q3 2015. 125 funds tracked by Wall St. Rank hold XLRN as of Q4 2015.

  • New Leaf Venture Partners reported no remaining Acceleron Pharma position as of Q4 2015 after selling out during the quarter.
  • New Leaf Venture Partners sold 114,621 Acceleron Pharma shares in Q4 2015, an estimated $2.85M.
  • New Leaf Venture Partners first reported a position in Acceleron Pharma in Q2 2015 and held it in 2 quarters.
  • New Leaf Venture Partners's Acceleron Pharma position peaked at $2.85M in Q3 2015.
  • 125 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2015.

Based on New Leaf Venture Partners's 13F filing for Q4 2015, filed 16 Feb 2016.